The Administrative Core is charged with leadership, oversight, fiscal, and general administrative responsibility for the Oregon Alzheimer Disease Center (OADC). The OADC Director works closely with the Executive Committee of the Center, which is composed of all the Core Leaders and other key OADC personnel. The Administrative Core coordinates the six cores of the Center through structured, regular meetings and interim reports. Members of individual Cores, having duties and necessary interactions within other related units of the Center, facilitate the integration of the OADC on a daily basis. In addition to managerial and supervisory duties, the Administrative Core also seeks to ensure that the OADC is positioned to respond to the needs of the greater community of scientists and other interested individuals engaged in activities relevant to research on Alzheimer disease and related disorders, especially as they relate to uncompromised brain aging and incipient or early dementia. This includes advising and encouraging young investigators, as well as relating to the concerns and requirements of established scientists with regard to their research. The Core also seeks to foster the movement of talented investigators from other fields into the brain aging and dementia arena. This process is facilitated by the OADC Pilot Project Grant mechanism organized annually by the Administrative Core. Overview of the general direction and quality of the Center is achieved through oversight and advice of the National Institute on Aging and two committees: the External and Internal Advisory Committees. The External Review process brings in an outside External Review Committee of experts to critically review the progress of the Center and issue a formal report. Similarly, but with a different, yet complementary perspective, the Internal Advisory Committee (composed of prominent local scientists and community leaders) also provides review and oversight to the OADC. Members of both review committees are also used to advise the OADC Director and Core Leaders on an as needed basis as well.
The Administrative Core of the Oregon Alzheimer Disease Center provides the necessary organizational structure, scientific direction and leadership to effectively operate the entire research center. In providing oversight and stewardship of the overall mission of the center sound fiscal, scientific and educational policies and practices are achieved targeted toward the goal of understanding the causes of dementia and ultimately their treatments.
|Alosco, Michael L; Duskin, Jonathan; Besser, Lilah M et al. (2017) Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set. J Alzheimers Dis 57:953-968|
|Kim, Julia; Schweizer, Tom A; Fischer, Corinne E et al. (2017) The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease. J Alzheimers Dis 55:381-389|
|Pandya, Seema Y; Lacritz, Laura H; Weiner, Myron F et al. (2017) Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition. Dement Geriatr Cogn Disord 43:204-214|
|Mattos, Meghan K; Snitz, Beth E; Lingler, Jennifer H et al. (2017) Older Rural- and Urban-Dwelling Appalachian Adults With Mild Cognitive Impairment. J Rural Health 33:208-216|
|Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738|
|Wardzala, Casia; Murchison, Charles; Loftis, Jennifer M et al. (2017) Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians. Psychopharmacology (Berl) :|
|Jutkowitz, Eric; MacLehose, Richard F; Gaugler, Joseph E et al. (2017) Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients. J Gerontol A Biol Sci Med Sci 72:251-258|
|Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384|
|Dodge, Hiroko H; Zhu, Jian; Woltjer, Randy et al. (2017) Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease. Alzheimers Dement 13:613-623|
|Boise, Linda; Hinton, Ladson; Rosen, Howard J et al. (2017) Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups. Alzheimer Dis Assoc Disord 31:135-140|
Showing the most recent 10 out of 421 publications